LU77659A1 - Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel - Google Patents

Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Info

Publication number
LU77659A1
LU77659A1 LU77659A LU77659A LU77659A1 LU 77659 A1 LU77659 A1 LU 77659A1 LU 77659 A LU77659 A LU 77659A LU 77659 A LU77659 A LU 77659A LU 77659 A1 LU77659 A1 LU 77659A1
Authority
LU
Luxembourg
Prior art keywords
piperidinoadamantane
manufacturing
products containing
medicinal products
medicinal
Prior art date
Application number
LU77659A
Other languages
English (en)
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Priority to LU77659A priority Critical patent/LU77659A1/de
Priority to DE19782822360 priority patent/DE2822360A1/de
Publication of LU77659A1 publication Critical patent/LU77659A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
LU77659A 1977-06-30 1977-06-30 Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel LU77659A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU77659A LU77659A1 (de) 1977-06-30 1977-06-30 Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE19782822360 DE2822360A1 (de) 1977-06-30 1978-05-23 Piperidinoadamantane, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77659A LU77659A1 (de) 1977-06-30 1977-06-30 Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
LU77659A1 true LU77659A1 (de) 1979-03-26

Family

ID=19728628

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77659A LU77659A1 (de) 1977-06-30 1977-06-30 Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Country Status (2)

Country Link
DE (1) DE2822360A1 (de)
LU (1) LU77659A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3242872B1 (de) * 2015-01-09 2019-07-03 Genentech, Inc. (piperidin-3-yl)(naphthalen-2-yl)methanon-derivate und verwandte verbindungen als inhibitoren der histon demethylase kdm2b zur behandlung von krebs

Also Published As

Publication number Publication date
DE2822360A1 (de) 1979-01-11

Similar Documents

Publication Publication Date Title
ATE9803T1 (de) 7-amino-1-cyclopropyl-4-oxo-1,4dihydronaphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
PT83013A (de) Tertiaere hydroxyalkylxanthine verfahren zu ihrer herstellung die sie enthaltende arzneimittel und ihre verwendung
PT67856A (de) Cephemderivate und verfahren zu ihrer herstellung
ATA970076A (de) Absorbierendes erzeugnis und verfahren zu seiner herstellung
ATA57178A (de) Behaelter sowie verafahren und vorrichtung zu seiner herstellung
PT68272A (de) Basische thioather und verfahren zu ihrer herstellung
PT69008A (de) N-substituierte omega-aminoalkanoyl-omega-amino-alkansauren und verfahren zu ihrer herstellung
PH19005A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
PT66858B (de) 2-benzylpyrrolidine verfahren zu ihrer herstellung und sieenthaltende arzneimittel
LU78814A1 (de) Arzneimittel zur bekaempfung von ulcera,oximether und verfahren zu ihrer herstellung
LU78625A1 (de) Substituierte 1-phenyl-2-pyrrolidin-2-yl-ethanole,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
LU79168A1 (de) Benzylpyrimidine,verfahren zu ihrer herstellung und diese enthaltende arzneimittel
LU80083A1 (de) Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung
LU79124A1 (de) Neue arzneimittelkombinationen und verfahren zu ihrer herstellung
AT368527B (de) Katalytische titankomponente und verfahren zu ihrer herstellung
DD134523A5 (de) Halbsynthetische 4''-amino-oleandomycin-derivate und verfahren zu ihrer herstellung
PT74077B (de) N-pyrimidinyl-carbaminsaureester verfahren zu ihrer herstellung und diese enthaltende arzneimittel
PT68015B (de) Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
LU79652A1 (de) 17b-hydroxy-4-androsten-3-one und verfahren zu ihrer herstellung
LU77659A1 (de) Piperidinoadamantane,verfahren zu ihrer herstellung und sie enthaltende arzneimittel
LU78974A1 (de) Neue 2,5-dihydro-1,2-thiazino(5,6-b)indol-3-carboxamid-1,1-dioxide,verfahren zu ihrer herstellung und diese enthaltende arzneimittel
PT67707B (de) Triazolo-thieno-diazepin-1-one verfahren zu ihrer herstellung und arzneimittel
LU77658A1 (de) Alkylsubstituierte piperidin-n-oxide,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel
LU77861A1 (de) 2-benzylpyrrolidine,verfahren zu ihrer herstellung und sie enthaltende arzneimittel
LU80632A1 (de) 3-di-n-propyl-acetoxy-benzodiazepin-2-one und verfahren zu deren herstellung